• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺中的筛状病变:着重于鉴别诊断及临床意义

Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.

作者信息

Destouni Maria, Lazaris Andreas C, Tzelepi Vasiliki

机构信息

Department of Cytopathology, Hippokrateion General Hospital of Athens, 11527 Athens, Greece.

First Department of Pathology, School of Medicine, The National and Kapodistrian University of Athens, 11527 Athens, Greece.

出版信息

Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041.

DOI:10.3390/cancers14133041
PMID:35804812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9264941/
Abstract

Cribriform glandular formations are characterized by a continuous proliferation of cells with intermingled lumina and can constitute a major or minor part of physiologic (normal central zone glands), benign (clear cell cribriform hyperplasia and basal cell hyperplasia), premalignant (high-grade prostatic intraepithelial neoplasia), borderline (atypical intraductal cribriform proliferation) or clearly malignant (intraductal, acinar, ductal and basal cell carcinoma) lesions. Each displays a different clinical course and variability in clinical management and prognosis. The aim of this review is to summarize the current knowledge regarding the morphological features, differential diagnosis, molecular profile and clinical significance of the cribriform-patterned entities of the prostate gland. Areas of controversy regarding their management, i.e., the grading of Intaductal Carcinoma, will also be discussed. Understanding the distinct nature of each cribriform lesion leads to the correct diagnosis and ensures accuracy in clinical decision-making, prognosis prediction and personalized risk stratification of patients.

摘要

筛状腺性结构的特征是细胞持续增殖,管腔相互交织,可构成生理性(正常中央区腺体)、良性(透明细胞筛状增生和基底细胞增生)、癌前病变(高级别前列腺上皮内瘤变)、交界性(非典型导管内筛状增生)或明确恶性(导管内、腺泡、导管和基底细胞癌)病变的主要或次要部分。每种病变都有不同的临床病程以及临床管理和预后的差异。本综述的目的是总结目前关于前列腺筛状结构实体的形态特征、鉴别诊断、分子特征和临床意义的知识。还将讨论其管理方面存在争议的领域,即导管内癌的分级。了解每种筛状病变的独特性质有助于正确诊断,并确保临床决策、预后预测和患者个性化风险分层的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/f142df3b4c6d/cancers-14-03041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/26e9d694ef99/cancers-14-03041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/cbc5d9ea2553/cancers-14-03041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/4fa4020a72ab/cancers-14-03041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/dbf6efc5cd57/cancers-14-03041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/d3109c767744/cancers-14-03041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/f142df3b4c6d/cancers-14-03041-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/26e9d694ef99/cancers-14-03041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/cbc5d9ea2553/cancers-14-03041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/4fa4020a72ab/cancers-14-03041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/dbf6efc5cd57/cancers-14-03041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/d3109c767744/cancers-14-03041-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3274/9264941/f142df3b4c6d/cancers-14-03041-g006.jpg

相似文献

1
Cribriform Patterned Lesions in the Prostate Gland with Emphasis on Differential Diagnosis and Clinical Significance.前列腺中的筛状病变:着重于鉴别诊断及临床意义
Cancers (Basel). 2022 Jun 21;14(13):3041. doi: 10.3390/cancers14133041.
2
Cribriform Lesions of the Prostate Gland.前列腺筛状病变。
Surg Pathol Clin. 2022 Dec;15(4):591-608. doi: 10.1016/j.path.2022.07.001. Epub 2022 Oct 13.
3
Spectrum of Cribriform Proliferations of the Prostate: From Benign to Malignant.前列腺筛状增生的范围:从良性到恶性。
Arch Pathol Lab Med. 2018 Aug;142(8):938-946. doi: 10.5858/arpa.2018-0005-RA.
4
Clinicopathological analysis of intraductal proliferative lesions of prostate: intraductal carcinoma of prostate, high-grade prostatic intraepithelial neoplasia, and atypical cribriform lesion.前列腺导管内增生性病变的临床病理分析:前列腺导管内癌、高级别前列腺上皮内瘤变和非典型筛状病变。
Hum Pathol. 2014 Aug;45(8):1572-81. doi: 10.1016/j.humpath.2014.03.011. Epub 2014 Apr 12.
5
Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.前列腺筛状癌和前列腺筛状上皮内瘤变:发病率及临床意义。
Am J Surg Pathol. 1998 Jul;22(7):840-8. doi: 10.1097/00000478-199807000-00006.
6
Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraductal carcinoma of the prostate.前列腺非典型筛状病变:临床意义、鉴别诊断及前列腺导管内癌的当前概念。
Adv Anat Pathol. 2012 Jul;19(4):270-8. doi: 10.1097/PAP.0b013e31825c6c0e.
7
Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.前列腺非典型筛状病变:与前列腺癌的关系及其对前列腺活检诊断的影响。
Am J Surg Pathol. 2010 Apr;34(4):470-7. doi: 10.1097/PAS.0b013e3181cfc44b.
8
ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.ETS 基因异常在前列腺非典型筛状病变中的意义:有助于鉴别前列腺导管内癌和筛状高级别前列腺上皮内瘤。
Am J Surg Pathol. 2010 Apr;34(4):478-85. doi: 10.1097/PAS.0b013e3181d6827b.
9
Unusual morphologic patterns of basal cell hyperplasia of the prostate.前列腺基底细胞增生的异常形态学模式。
Am J Surg Pathol. 2002 Feb;26(2):237-43. doi: 10.1097/00000478-200202000-00011.
10
Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.前列腺导管内癌:39名泌尿外科病理学家的观察者间再现性调查
Ann Diagn Pathol. 2014 Dec;18(6):333-42. doi: 10.1016/j.anndiagpath.2014.08.010. Epub 2014 Sep 3.

引用本文的文献

1
Intermediate risk prostate tumors contain lethal subtypes.中度风险前列腺肿瘤包含致死性亚型。
Front Urol. 2024;4. doi: 10.3389/fruro.2024.1487873. Epub 2025 Jan 14.
2
Intraductal Carcinoma of the Prostate versus Simulants: A Differential Diagnosis Growing in Clinical Impact.前列腺导管内癌与模拟物:临床影响日益增大的鉴别诊断
Cancers (Basel). 2024 Mar 8;16(6):1097. doi: 10.3390/cancers16061097.
3
Optimization of a Three-Dimensional Culturing Method for Assessing the Impact of Cisplatin on Notch Signaling in Head and Neck Squamous Cell Carcinoma (HNSCC).

本文引用的文献

1
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.前列腺导管腺癌:发病率、临床表现、预后及治疗的系统评价和荟萃分析
BJUI Compass. 2021 Jan 5;2(1):13-23. doi: 10.1002/bco2.60. eCollection 2021 Jan.
2
Contemporary Grading of Prostate Cancer: The Impact of Grading Criteria and the Significance of the Amount of Intraductal Carcinoma.当代前列腺癌分级:分级标准的影响及导管内癌数量的意义
Cancers (Basel). 2021 Oct 29;13(21):5454. doi: 10.3390/cancers13215454.
3
Diagnosis of "cribriform" prostatic adenocarcinoma: an interobserver reproducibility study among urologic pathologists with recommendations.
评估顺铂对头颈部鳞状细胞癌(HNSCC)中Notch信号通路影响的三维培养方法的优化
Cancers (Basel). 2023 Nov 7;15(22):5320. doi: 10.3390/cancers15225320.
4
DNA Damage Repair Pathways in Prostate Cancer: A Narrative Review of Molecular Mechanisms, Emerging Biomarkers and Therapeutic Targets in Precision Oncology.前列腺癌中的 DNA 损伤修复途径:精准肿瘤学中分子机制、新兴生物标志物和治疗靶点的叙事性综述。
Int J Mol Sci. 2023 Jul 13;24(14):11418. doi: 10.3390/ijms241411418.
5
Correlations of PTEN and ERG Immunoexpression in Prostate Carcinoma and Lesions Related to Its Natural History: Clinical Perspectives.前列腺癌中PTEN与ERG免疫表达的相关性及其与自然病程相关病变:临床视角
Curr Issues Mol Biol. 2023 Mar 25;45(4):2767-2780. doi: 10.3390/cimb45040181.
“筛状”前列腺腺癌的诊断:一项针对泌尿外科病理学家的观察者间可重复性研究及建议
Am J Cancer Res. 2021 Aug 15;11(8):3990-4001. eCollection 2021.
4
Intraductal Carcinoma of the Prostate: Extreme Nuclear Size Is Not a Diagnostic Parameter.前列腺导管内癌:核的极端大小不是诊断参数。
Am J Surg Pathol. 2021 Nov 1;45(11):1527-1533. doi: 10.1097/PAS.0000000000001776.
5
Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.筛状前列腺癌:临床病理和分子学考虑。
Urology. 2021 Sep;155:47-54. doi: 10.1016/j.urology.2021.05.028. Epub 2021 May 28.
6
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal Therapy.早期前列腺癌异质性驱动其演进并对强化激素治疗产生抵抗。
Eur Urol. 2021 Dec;80(6):746-757. doi: 10.1016/j.eururo.2021.03.009. Epub 2021 Mar 27.
7
Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.高强度雄激素剥夺治疗在前路前列腺切除术治疗高危局限性前列腺癌的随机 II 期临床试验结果。
J Urol. 2021 Jul;206(1):80-87. doi: 10.1097/JU.0000000000001702. Epub 2021 Mar 8.
8
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.管状变异型前列腺癌与无转移生存期显著缩短相关。
Eur J Cancer. 2021 May;148:440-450. doi: 10.1016/j.ejca.2020.12.030. Epub 2021 Mar 5.
9
Association between BRCA2 alterations and intraductal and cribriform histologies in prostate cancer.BRCA2改变与前列腺癌导管内和筛状组织学之间的关联。
Eur J Cancer. 2021 Apr;147:74-83. doi: 10.1016/j.ejca.2021.01.027. Epub 2021 Feb 21.
10
A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.在筛状前列腺癌中富集了一组独特的与癌症相关的成纤维细胞。
J Pathol Clin Res. 2021 May;7(3):271-286. doi: 10.1002/cjp2.205. Epub 2021 Feb 18.